FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

7502011000036104: Eligard 4 Month (leuprorelin acetate 30 mg) modified release injection, 30 mg syringe (trade product unit of use)


Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
449751000036113 Eligard 4 Month (leuprorelin acetate 30 mg) modified release injection, 30 mg syringe (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
449771000036115 Eligard 4 Month (leuprorelin acetate 30 mg) modified release injection, 30 mg syringe en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Eligard 4 Month (leuprorelin acetate 30 mg) modified release injection, 30 mg syringe Is a trade product unit of use true Inferred relationship Some
Eligard 4 Month (leuprorelin acetate 30 mg) modified release injection, 30 mg syringe Is a Eligard 4 Month true Inferred relationship Some
Eligard 4 Month (leuprorelin acetate 30 mg) modified release injection, 30 mg syringe Is a leuprorelin acetate 30 mg modified release injection, syringe true Inferred relationship Some
Eligard 4 Month (leuprorelin acetate 30 mg) modified release injection, 30 mg syringe has unit of use syringe true Inferred relationship Some 1204859557
Eligard 4 Month (leuprorelin acetate 30 mg) modified release injection, 30 mg syringe has manufactured dose form modified release injection true Inferred relationship Some
Eligard 4 Month (leuprorelin acetate 30 mg) modified release injection, 30 mg syringe has intended active ingredient leuprorelin true Inferred relationship Some 1204859556
Eligard 4 Month (leuprorelin acetate 30 mg) modified release injection, 30 mg syringe has Australian BoSS leuprorelin acetate true Inferred relationship Some 1204859556

Inbound Relationships Type Active Source Characteristic Refinability Group
Eligard 4 Month (1 x 30 mg syringe, 1 x inert diluent syringe), 1 pack has TPUU True Eligard 4 Month (leuprorelin acetate 30 mg) modified release injection, 30 mg syringe Inferred relationship Some 1
Eligard 4 Month (1 x 30 mg syringe, 1 x inert diluent syringe), 1 pack has TPUU True Eligard 4 Month (leuprorelin acetate 30 mg) modified release injection, 30 mg syringe Inferred relationship Some 2

Reference Sets

Trade product unit of use reference set

Back to Start